Common Stock SEC Reporting - Current
Pink Current Information
Contact Info
  • 4134 Business Park Drive
  • Amarillo, TX 79110-4225

Business Description

Not Available

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001014763
Fiscal Year End 7/10
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: TX, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Joseph Cummins President, CEO, CFO
Bernard Cohen CFO, Vice President
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Amarillo Biosciences, Inc. successfully emerged from Chapter 11 Bankruptcy. The Final Decree closing the case was signed by Judge Robert L. Jones of the United States Bankruptcy Court for the Northern District of Texas, on January 23, 2015, in Case No. 13-20393-RJL-11. All documents referenced in this statement as well as all documents filed in this case are available and may be reviewed at the following website
  • On October 31, 2013, Amarillo Biosciences, Inc., the Debtor filed a voluntary petition for reorganization under Chapter 11 of the United States Bankruptcy Code, in the United States Bankruptcy Court for the Northern District of Texas, Amarillo Division.
AMAR Security Details
Share Structure
Market Value1 $6,058,038 a/o Oct 20, 2017
Authorized Shares Not Available
Outstanding Shares 22,437,176 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Shareholders of Record 1,687 a/o Mar 30, 2016
Short Selling Data
Short Interest 11,322 (509.36%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security